Login / Signup
Blocking PD-L1 for anti-liver cancer immunity: USP22 represents a critical cotarget.
Xing Huang
Xiaozhen Zhang
Xueli Bai
Tingbo Liang
Published in:
Cellular & molecular immunology (2019)
Keyphrases
</>